Sec Form 3 Filing - Murphy Sean @ TriSalus Life Sciences, Inc. - 2023-08-10

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Murphy Sean 2. Issuer Name and Ticker or Trading Symbol TriSalus Life Sciences, Inc. [ TLSI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) 6272 W. 91ST AVENUE 3. Date of Earliest Transaction (MM/DD/YY) 08/10/2023 (Street) WESTMINSTER, CO80031 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 357,535 ( 1 ) I By Murphy Family Trust 2012 ( 2 ) Common Stock 167,732 ( 1 ) I By Sean E Murphy TTEE U/A 2/4/2004 Common Stock 16,644 ( 1 ) ( 3 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (right to buy) $ 2.43 ( 4 ) 11/02/2031 Common Stock 4,943 ( 1 ) D Employee Stock Option (right to buy) $ 2.43 ( 5 ) 01/18/2032 Common Stock 12,359 ( 1 ) D Employee Stock Option (right to buy) $ 2.43 ( 6 ) 07/12/2032 Common Stock 123,592 ( 1 ) D Employee Stock Option (right to buy) $ 10.3 ( 7 ) 05/18/2033 Common Stock 31,287 ( 1 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Murphy Sean 6272 W. 91ST AVENUE WESTMINSTER, CO80031 X Chief Financial Officer Signatures /s/ Sean Murphy 08/14/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director and an executive officer of the Issuer. The Reporting Person was appointed as a director and an executive officer of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.). ( 2 )The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012. ( 3 )Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on October 5, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. ( 4 )The shares subject to this stock option vest in 48 equal monthly installments from October 1, 2021, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. ( 5 )The shares subject to this stock option vest in 48 equal monthly installments from January 19, 2022, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. ( 6 )Twenty-five percent of the shares subject to the option vested on July 13, 2023, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. ( 7 )The shares subject to this stock option vest in 48 equal monthly installments from May 19, 2023, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.